Combination of Novel Nitrification Inhibitors and Herbicides as Well as Combination of (Thio)Phosphoric Acid Triamides and Herbicides
First Claim
Patent Images
1. A composition comprising:
- a) at least one (thio)phosphoric acid triamide (T) according to the general formula (Ia)
Ra1Ra2N—
P(X)(NH2)2
(Ia)whereinX is oxygen or sulfur;
Ra1 is a C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, or dialkylaminocarbonyl group;
Ra2 is H, orRa1 and Ra2 together with the nitrogen atom linking them define a 5- or 6-membered saturated or unsaturated heterocyclic radical, which optionally comprises 1 or 2 further heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur;
andb) at least one herbicide selected from the group consisting of;
(i) amino acid derivatives selected from the group consisting of glyphosate (B.2.1), glufosinate (B.2.2), sulfosate (B.2.3), and bilanafos;
(ii) acetamides selected from the group consisting of acetochlor (B.1.1), alachlor, butachlor, dimethachlor, dimethenamid (B.1.2), flufenacet (B.1.3), mefenacet (B.1.4), metolachlor (B.1.5), metazachlor (B.1.6), napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, and thenylchlor;
(iii) aryloxyphenoxypropionates selected from the group consisting of clodinafop (B.3.1), cyhalofop-butyl, fenoxaprop (B.3.2), fluazifop (B.3.3), haloxyfop (B.3.4), metamifop, propaquizafop (B.3.5), quizalofop, and quizalofop-P-tefuryl;
(iv) bipyridyls selected from the group consisting of diquat, and paraquat (B.4.1);
(v) (thio)carbamates selected from the group consisting of asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham (B.5.1), prosulfocarb, pyributicarb, thiobencarb, and triallate;
(vi) cyclohexanediones selected from the group consisting of butroxydim, clethodim (B.6.1), cycloxydim (B.6.2), profoxydim (B.6.3), sethoxydim (B.6.4), tepraloxydim (B.6.5), and tralkoxydim;
(vii) dinitroanilines selected from the group consisting of benfluralin, ethalfluralin, oryzalin, pendimethalin (B.7.1), prodiamine (B.7.2), and trifluralin (B.7.3);
(viii) diphenyl ethers selected from the group consisting of acifluorfen (B.8.1), aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, and oxyfluorfen;
(ix) hydroxybenzonitriles selected from the group consisting of bomoxynil (B.9.1), dichlobenil, and ioxynil;
(x) imidazolinones selected from the group consisting of imazamethabenz, imazamox (B.10.1), imazapic (B.10.2), imazapyr (B.10.3), imazaquin (B.10.4), and imazethapyr (B.10.5);
(xi) phenoxy acetic acids selected from the group consisting of clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D) (B.11.1), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, and Mecoprop;
(xii) pyrazines selected from the group consisting of chloridazon (B.11.2), flufenpyr-ethyl, fluthiacet, norflurazon, and pyridate;
(xiii) pyridines selected from the group consisting of aminopyralid, clopyralid (B.12.1), diflufenican, dithiopyr, fluridone, fluroxypyr (B.12.2), picloram (B.12.3), picolinafen (B.12.4), and thiazopyr;
(xiv) sulfonyl ureas selected from the group consisting of amidosulfuron, azimsulfuron, bensulfuron (B.13.1), chlorimuron-ethyl (B.13.2), chlorsulfuron, cinosulfuron, cyclosulfamuron (B.13.3), ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron (B.13.4), mesosulfuron (B.13.5), metazosulfuron, metsulfuron-methyl (B.13.6), nicosulfuron (B.13.7), oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron (B.13.8), sulfometuron, sulfosulfuron, thifensulfuron, triasulfuron, tribenuron (B.13.10), trifloxysulfuron, triflusulfuron (B.13.9), tritosulfuron, and 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea;
(xv) triazines selected from the group consisting of ametryn, atrazine (B.14.1), cyanazine, dimethametryn, ethiozin, hexazinone (B.14.2), metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, and triaziflam;
(xvi) ureas selected from the group consisting of chlorotoluron, daimuron, diuron (B.15.1), fluometuron, isoproturon, linuron, methabenzthiazuron, and tebuthiuron;
(xvii) other acetolactate synthase inhibitors selected from the group consisting of bispyribac-sodium, cloransulam-methyl, diclosulam, florasulam (B.16.1), flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone (B.16.2), and pyroxsulam; and
(xviii) amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone (B.17.1), benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl (B.17.2), chlorthal, cinmethylin (B.17.3), clomazone (B.17.4), cumyluron, cyprosulfamide, dicamba (B.17.5), difenzoquat, diflufenzopyr (B.17.6), Drechslera monoceras, endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac (B.17.7), quinmerac (B.17.8), mesotrione (B.17.9), methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil (B.17.10), sulcotrione (B.17.11), sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone (B.17.12), (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyridin-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester.
3 Assignments
0 Petitions
Accused Products
Abstract
A composition including (a) at least one (thio)phosphoric acid triamide (T) according to the general formula (Ia)
Ra1Ra2N—P(X)(NH2)2 (Ia)
wherein X is oxygen or sulfur; Ra1 is a C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, or dialkylaminocarbonyl group; Ra2 is H; or Ra1 and Ra2 together with the nitrogen atom linking them define a 5- or 6-membered saturated or unsaturated heterocyclic radical, which optionally comprises 1 or 2 further heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur; and (b) at least one specific herbicide.
10 Citations
28 Claims
-
1. A composition comprising:
-
a) at least one (thio)phosphoric acid triamide (T) according to the general formula (Ia)
Ra1Ra2N—
P(X)(NH2)2
(Ia)wherein X is oxygen or sulfur; Ra1 is a C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, or dialkylaminocarbonyl group; Ra2 is H, or Ra1 and Ra2 together with the nitrogen atom linking them define a 5- or 6-membered saturated or unsaturated heterocyclic radical, which optionally comprises 1 or 2 further heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur; and b) at least one herbicide selected from the group consisting of; (i) amino acid derivatives selected from the group consisting of glyphosate (B.2.1), glufosinate (B.2.2), sulfosate (B.2.3), and bilanafos; (ii) acetamides selected from the group consisting of acetochlor (B.1.1), alachlor, butachlor, dimethachlor, dimethenamid (B.1.2), flufenacet (B.1.3), mefenacet (B.1.4), metolachlor (B.1.5), metazachlor (B.1.6), napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, and thenylchlor; (iii) aryloxyphenoxypropionates selected from the group consisting of clodinafop (B.3.1), cyhalofop-butyl, fenoxaprop (B.3.2), fluazifop (B.3.3), haloxyfop (B.3.4), metamifop, propaquizafop (B.3.5), quizalofop, and quizalofop-P-tefuryl; (iv) bipyridyls selected from the group consisting of diquat, and paraquat (B.4.1); (v) (thio)carbamates selected from the group consisting of asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham (B.5.1), prosulfocarb, pyributicarb, thiobencarb, and triallate; (vi) cyclohexanediones selected from the group consisting of butroxydim, clethodim (B.6.1), cycloxydim (B.6.2), profoxydim (B.6.3), sethoxydim (B.6.4), tepraloxydim (B.6.5), and tralkoxydim; (vii) dinitroanilines selected from the group consisting of benfluralin, ethalfluralin, oryzalin, pendimethalin (B.7.1), prodiamine (B.7.2), and trifluralin (B.7.3); (viii) diphenyl ethers selected from the group consisting of acifluorfen (B.8.1), aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, and oxyfluorfen; (ix) hydroxybenzonitriles selected from the group consisting of bomoxynil (B.9.1), dichlobenil, and ioxynil; (x) imidazolinones selected from the group consisting of imazamethabenz, imazamox (B.10.1), imazapic (B.10.2), imazapyr (B.10.3), imazaquin (B.10.4), and imazethapyr (B.10.5); (xi) phenoxy acetic acids selected from the group consisting of clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D) (B.11.1), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, and Mecoprop; (xii) pyrazines selected from the group consisting of chloridazon (B.11.2), flufenpyr-ethyl, fluthiacet, norflurazon, and pyridate; (xiii) pyridines selected from the group consisting of aminopyralid, clopyralid (B.12.1), diflufenican, dithiopyr, fluridone, fluroxypyr (B.12.2), picloram (B.12.3), picolinafen (B.12.4), and thiazopyr; (xiv) sulfonyl ureas selected from the group consisting of amidosulfuron, azimsulfuron, bensulfuron (B.13.1), chlorimuron-ethyl (B.13.2), chlorsulfuron, cinosulfuron, cyclosulfamuron (B.13.3), ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron (B.13.4), mesosulfuron (B.13.5), metazosulfuron, metsulfuron-methyl (B.13.6), nicosulfuron (B.13.7), oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron (B.13.8), sulfometuron, sulfosulfuron, thifensulfuron, triasulfuron, tribenuron (B.13.10), trifloxysulfuron, triflusulfuron (B.13.9), tritosulfuron, and 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea; (xv) triazines selected from the group consisting of ametryn, atrazine (B.14.1), cyanazine, dimethametryn, ethiozin, hexazinone (B.14.2), metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, and triaziflam; (xvi) ureas selected from the group consisting of chlorotoluron, daimuron, diuron (B.15.1), fluometuron, isoproturon, linuron, methabenzthiazuron, and tebuthiuron; (xvii) other acetolactate synthase inhibitors selected from the group consisting of bispyribac-sodium, cloransulam-methyl, diclosulam, florasulam (B.16.1), flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone (B.16.2), and pyroxsulam; and (xviii) amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone (B.17.1), benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl (B.17.2), chlorthal, cinmethylin (B.17.3), clomazone (B.17.4), cumyluron, cyprosulfamide, dicamba (B.17.5), difenzoquat, diflufenzopyr (B.17.6), Drechslera monoceras, endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac (B.17.7), quinmerac (B.17.8), mesotrione (B.17.9), methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil (B.17.10), sulcotrione (B.17.11), sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone (B.17.12), (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyridin-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester. - View Dependent Claims (2, 3, 4, 5, 10)
-
-
6. A method for at least one of increasing the health of a plant and increasing the herbicidal activity of a herbicide, the method comprising:
-
treating at least one of (a) a plant growing on at least one of soil or soil substituents, and (b) and at least one of the locus, soil, and soil substituents where the plant is at least one of growing or intended to grow, with a) at least one (thio)phosphoric acid triamide (T) according to the general formula (Ia)
Ra1Ra2N—
P(X)(NH2)2
(Ia)wherein X is oxygen or sulfur; Ra1 is a C1 to C20 alkyl, C3 to C20 cycloalkyl, C6 to C20 aryl, or dialkylaminocarbonyl group; Ra2 is H, or Ra1 and Ra2 together with the nitrogen atom linking them define a 5- or 6-membered saturated or unsaturated heterocyclic radical, which optionally comprises 1 or 2 further heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur and b) at least one herbicide selected from the group consisting of (i) amino acid derivatives selected from the group consisting of glyphosate (B.2.1), glufosinate (B.2.2), sulfosate (B.2.3), and bilanafos; (ii) acetamides selected from the group consisting of acetochlor (B.1.1), alachlor, butachlor, dimethachlor, dimethenamid (B.1.2), flufenacet (B.1.3), mefenacet (B.1.4), metolachlor (B.1.5), metazachlor (B.1.6), napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, and thenylchlor; (iii) aryloxyphenoxypropionates selected from the group consisting of clodinafop (B.3.1), cyhalofop-butyl, fenoxaprop (B.3.2), fluazifop (B.3.3), haloxyfop (B.3.4), metamifop, propaquizafop (B.3.5), quizalofop, and quizalofop-P-tefuryl; (iv) bipyridyls selected from the group consisting of diquat, and paraquat (B.4.1); (v) (thio)carbamates selected from the group consisting of asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham (B.5.1), prosulfocarb, pyributicarb, thiobencarb, and triallate; (vi) cyclohexanediones selected from the group consisting of butroxydim, clethodim (B.6.1), cycloxydim (B.6.2), profoxydim (B.6.3), sethoxydim (B.6.4), tepraloxydim (B.6.5), and tralkoxydim; (vii) dinitroanilines selected from the group consisting of benfluralin, ethalfluralin, oryzalin, pendimethalin (B.7.1), prodiamine (B.7.2), and trifluralin (B.7.3); (viii) diphenyl ethers selected from the group consisting of acifluorfen (B.8.1), aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, and oxyfluorfen; (ix) hydroxybenzonitriles selected from the group consisting of bomoxynil (B.9.1), dichlobenil, and ioxynil; (x) imidazolinones selected from the group consisting of imazamethabenz, imazamox (B.10.1), imazapic (B.10.2), imazapyr (B.10.3), imazaquin (B.10.4), and imazethapyr (B.10.5); (xi) phenoxy acetic acids selected from the group consisting of clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D) (B.11.1), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, and Mecoprop; (xii) pyrazines selected from the group consisting of chloridazon (B.11.2), flufenpyr-ethyl, fluthiacet, norflurazon, and pyridate; (xiii) pyridines selected from the group consisting of aminopyralid, clopyralid (B.12.1), diflufenican, dithiopyr, fluridone, fluroxypyr (B.12.2), picloram (B.12.3), picolinafen (B.12.4), and thiazopyr; (xiv) sulfonyl ureas selected from the group consisting of amidosulfuron, azimsulfuron, bensulfuron (B.13.1), chlorimuron-ethyl (B.13.2), chlorsulfuron, cinosulfuron, cyclosulfamuron (B.13.3), ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron (B.13.4), mesosulfuron (B.13.5), metazosulfuron, metsulfuron-methyl (B.13.6), nicosulfuron (B.13.7), oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron (B.13.8), sulfometuron, sulfosulfuron, thifensulfuron, triasulfuron, tribenuron (B.13.10), trifloxysulfuron, triflusulfuron (B.13.9), tritosulfuron, and 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea; (xv) triazines selected from the group consisting of ametryn, atrazine (B.14.1), cyanazine, dimethametryn, ethiozin, hexazinone (B.14.2), metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, and triaziflam; (xvi) ureas selected from the group consisting of chlorotoluron, daimuron, diuron (B.15.1), fluometuron, isoproturon, linuron, methabenzthiazuron, and tebuthiuron; (xvii) other acetolactate synthase inhibitors selected from the group consisting of bispyribac-sodium, cloransulam-methyl, diclosulam, florasulam (B.16.1), flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone (B.16.2), and pyroxsulam; and (xviii) amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone (B.17.1), benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl (B.17.2), chlorthal, cinmethylin (B.17.3), clomazone (B.17.4), cumyluron, cyprosulfamide, dicamba (B.17.5), difenzoquat, diflufenzopyr (B.17.6), Drechslera monoceras, endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac (B.17.7), quinmerac (B.17.8), mesotrione (B.17.9), methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil (B.17.10), sulcotrione (B.17.11), sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone (B.17.12), (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyridin-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester. - View Dependent Claims (7, 8, 9, 26, 27, 28)
-
-
11-25. -25. (canceled)
Specification